Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Safety of gadoterate meglumine in Southwest China (multicenter observational study)
ChiCTR2000040696Phase 4Not yet recruiting
- Sponsor
- Affiliated Hospital of North Sichuan Medical College
- Start
- Nov 2020
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label, single-arm trial of gadoterate meglumine in None, sponsored by Affiliated Hospital of North Sichuan Medical College. Primary endpoint: Adverse events. Planned start Nov 2020; status: not yet recruiting.
02
Drugs
gadoterate meglumine
Beyond the preview
Go deeper on ChiCTR2000040696.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR2000040696.